AR028579A1 - Metodo para el tratamiento de la sequedad vaginal, con agonistas del receptor de acetilcolina nicotinica - Google Patents
Metodo para el tratamiento de la sequedad vaginal, con agonistas del receptor de acetilcolina nicotinicaInfo
- Publication number
- AR028579A1 AR028579A1 ARP010102329A ARP010102329A AR028579A1 AR 028579 A1 AR028579 A1 AR 028579A1 AR P010102329 A ARP010102329 A AR P010102329A AR P010102329 A ARP010102329 A AR P010102329A AR 028579 A1 AR028579 A1 AR 028579A1
- Authority
- AR
- Argentina
- Prior art keywords
- acetilcoline
- drought
- nicotinic
- vaginal
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/423—Oxazoles condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4412—Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/465—Nicotine; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Endocrinology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Pyrrole Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Hydrogenated Pyridines (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/574,831 US6448276B1 (en) | 2000-05-17 | 2000-05-17 | Method for treating vaginal dryness with nicotinic acetylcholine receptor agonists |
Publications (1)
Publication Number | Publication Date |
---|---|
AR028579A1 true AR028579A1 (es) | 2003-05-14 |
Family
ID=24297829
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP010102329A AR028579A1 (es) | 2000-05-17 | 2001-05-16 | Metodo para el tratamiento de la sequedad vaginal, con agonistas del receptor de acetilcolina nicotinica |
Country Status (6)
Country | Link |
---|---|
US (1) | US6448276B1 (es) |
EP (1) | EP1253916A1 (es) |
JP (1) | JP2003533475A (es) |
AR (1) | AR028579A1 (es) |
AU (1) | AU2001261835A1 (es) |
WO (1) | WO2001087288A2 (es) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020061281A1 (en) * | 1999-07-06 | 2002-05-23 | Osbakken Robert S. | Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis |
US6576224B1 (en) | 1999-07-06 | 2003-06-10 | Sinuspharma, Inc. | Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis |
MXPA05004121A (es) * | 2002-10-18 | 2006-02-17 | Molichem Medicines Inc | Metodos para tratar la enfermedad de ojo reseco con lantibioticos. |
US7479481B2 (en) * | 2004-05-06 | 2009-01-20 | Molichem Medicines, Inc. | Treatment of ocular diseases and disorders using lantibiotic compositions |
CA2565457A1 (en) * | 2004-05-06 | 2005-11-17 | Molichem Medicines, Inc. | Treatment of membrane-associated diseases and disorders using lantibiotic containing compositions |
FR2889188B1 (fr) * | 2005-07-28 | 2007-09-07 | Servier Lab | Nouveaux composes 1,1-pyridinylaminocyclopropanamines polysubstitues, leur procede de preparation et les compositions phamaceutiques qui les contiennent |
WO2007055928A1 (en) * | 2005-11-03 | 2007-05-18 | Targacept, Inc. | 5-membered ring metanicotine analogs |
TW200901974A (en) * | 2007-01-16 | 2009-01-16 | Wyeth Corp | Compounds, compositions, and methods of making and using them |
WO2010026134A1 (en) * | 2008-09-02 | 2010-03-11 | Neurosearch A/S | Triazole derivatives and their use as nicotinic acetylcholine receptor modulators |
US20110002966A1 (en) * | 2009-07-01 | 2011-01-06 | Alex Lovett | Vaginal Suppository System and Method |
US20110195987A1 (en) * | 2009-10-05 | 2011-08-11 | Thomas Najarian | Treatment with cholinergic agonists |
US20130195780A1 (en) * | 2010-09-17 | 2013-08-01 | Rock Creek Pharmaceuticals, Inc. | Skin Care Products Contianing Anatabine Or Derivative Thereof |
AU2011325975B2 (en) * | 2010-11-12 | 2015-11-26 | The University Of Utah Research Foundation | Intravaginal devices for controlled delivery of lubricants |
EP2701704B1 (en) * | 2011-04-28 | 2016-04-13 | RCP Development, Inc. | Methods of administering anatabine to treat autism spectrum disorders and seizure disorders |
CA2847199C (en) | 2011-08-29 | 2022-03-22 | Rock Creek Pharmaceuticals, Inc. | Product comprising anatabine or salts thereof, vitamin a and vitamin d3 and pharmaceutical compositions thereof used for anti-inflammation support |
WO2016161051A1 (en) * | 2015-03-31 | 2016-10-06 | Srq Patent Holdings, Llc | Skin care products containing isomyosmine |
EP3416643B1 (en) * | 2016-02-16 | 2021-07-07 | Mymd Pharmaceuticals, Inc. | Methods of increasing hair growth and improving hair appearance |
WO2018081427A1 (en) | 2016-10-26 | 2018-05-03 | Revive Pharmaceuticals, Llc | Treating sexual dysfunction |
WO2018093369A1 (en) * | 2016-11-17 | 2018-05-24 | Goren Ofer A | Treatment of sexual dysfunction and for improved sexual quality of life |
CA3049670A1 (en) * | 2017-01-08 | 2018-07-12 | Olive Therapeutics, LLC | Treatment of sexual dysfunction |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE230989T1 (de) | 1992-08-31 | 2003-02-15 | Univ Florida | Anabasein derivate zur behandlung von degenerativen erkrankungen des nervensystems |
US5817679A (en) | 1993-04-01 | 1998-10-06 | University Of Virginia | 7-Azabicyclo 2.2.1!-heptane and -heptene derivatives as cholinergic receptor ligands |
US5723477A (en) | 1994-11-10 | 1998-03-03 | Sibia Neurosciences, Inc. | Modulators of acetylcholine receptors |
US5583140A (en) | 1995-05-17 | 1996-12-10 | Bencherif; Merouane | Pharmaceutical compositions for the treatment of central nervous system disorders |
US5629325A (en) | 1996-06-06 | 1997-05-13 | Abbott Laboratories | 3-pyridyloxymethyl heterocyclic ether compounds useful in controlling chemical synaptic transmission |
US5830904A (en) | 1997-02-05 | 1998-11-03 | University Of Kentucky Research Foundation | Lobeline compounds as a treatment for psychostimulant abuse and withdrawal, and for eating disorders |
US5861423A (en) | 1997-02-21 | 1999-01-19 | Caldwell; William Scott | Pharmaceutical compositions incorporating aryl substituted olefinic amine compounds |
WO1999043322A1 (en) * | 1998-02-24 | 1999-09-02 | Wake Forest University | Method for the treatment of pain, including chronic and female specific pain |
-
2000
- 2000-05-17 US US09/574,831 patent/US6448276B1/en not_active Expired - Fee Related
-
2001
- 2001-05-09 JP JP2001583756A patent/JP2003533475A/ja active Pending
- 2001-05-09 EP EP01935773A patent/EP1253916A1/en not_active Withdrawn
- 2001-05-09 AU AU2001261835A patent/AU2001261835A1/en not_active Abandoned
- 2001-05-09 WO PCT/US2001/040714 patent/WO2001087288A2/en not_active Application Discontinuation
- 2001-05-16 AR ARP010102329A patent/AR028579A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
EP1253916A1 (en) | 2002-11-06 |
AU2001261835A1 (en) | 2001-11-26 |
WO2001087288A2 (en) | 2001-11-22 |
WO2001087288A8 (en) | 2002-08-29 |
JP2003533475A (ja) | 2003-11-11 |
US6448276B1 (en) | 2002-09-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR028579A1 (es) | Metodo para el tratamiento de la sequedad vaginal, con agonistas del receptor de acetilcolina nicotinica | |
AR028026A1 (es) | Metodo para el tratamiento de la enfermedad del ojo seco con agonistas del receptor nicotinico de acetilcolina | |
LTPA2019521I1 (lt) | Rapamicino darinys, skirtas kieto naviko, susijusio su nereguliuojama angiogeneze, gydymui | |
EE200300246A (et) | EP4 retseptori suhtes selektiivsed agonistid osteoporoosi raviks | |
PL363907A1 (en) | Fused pyridine derivatives for use as vanilloid receptor antagonists for treating pain. | |
BR0117199B1 (pt) | dispositivo para realização de osteosìntese. | |
DOP2005000024A (es) | 2,3,4,5-tetrahidro-1h-benzo[d]azepinas 6-sustituidas como agonistas del receptor 5-ht2c | |
DK1110949T3 (da) | EP4-receptorselektive agonister, som er anvendelige ved behandling af osteoporose | |
ZA200502247B (en) | Selected CGRP antagonists, method for production and use thereof as medicament. | |
DE602005010109D1 (de) | 1,1a,5,5a-tetrahydro-3-thia-cyclopropaäaüpentaleneptor-agonisten | |
DE502004002801D1 (de) | Bohrlochbehandlungsmittel, enthaltend ethercarbonsäuren | |
BR0315138B8 (pt) | aplicador de dispositivo para incontinÊncia vaginal. | |
IL178887A0 (en) | Novel beta agonists, method for producing the same and their use as drugs | |
MA28576B1 (fr) | Procede de preparation de derives n-piperidino-1,5-diphenylpyrazole-3-carboxamide. | |
NO20020574L (no) | Substituerte 1,5-dihydropyrrol-2-on derivater som er virksomme som NMDA-reseptorantagonister for behandlingen avsmertetilstanden | |
PT1355639E (pt) | Derivados de carboestirilo substituidos como agonistas do subtipo de receptores 5-ht1a | |
NO20015259L (no) | Substituerte bisykliske heterosykler, fremgangsmåte for deres fremstilling og deres anvendelse som antifedme oghyperkolesterolemiske midler | |
NO20054168D0 (no) | Substituerte 3-(benzoylureido)-tiofenderivater, fremgangsmate for fremstilling og anvendelse derav | |
NO20032304L (no) | Anvendelse av selektive dopamin D4-reseptoragonister for behandling av seksuell dysfunksjon | |
DK1307237T3 (da) | Perfluoralkylholdige komplekser med polære grupper, fremgangsmåde til fremstilling og anvendelse heraf | |
AP2006003613A0 (en) | Oral formulations for 5-HT-receptor agonists, usesand methods of treatment employing the same | |
PT1317430E (pt) | Derivados de (2-azabiciclo[2.2.1]hepta-7-il)-metanol como agonistas do receptor nocotinico de acetilcolina | |
SE0001373D0 (sv) | NPY Y1 receptor agonists and antagonists | |
ES1047686Y (es) | Mecanismo de bloqueo del resbalon para picaportes. | |
ES1047158Y (es) | Dispositivo para encofrar, mejorado. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |